Celcuity (CELC) Total Current Liabilities (2016 - 2025)
Celcuity (CELC) reported Total Current Liabilities of $44.2 million for Q4 2025, up 39.18% on a YoY basis from $31.7 million in Q4 2024, and up 13.82% quarter-over-quarter from $38.8 million in Q3 2025.
Celcuity (CELC) Total Current Liabilities (2016 - 2025) Analysis & Trends
Celcuity has reported Total Current Liabilities for 10 years, with the latest figure at $44.2 million in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 39.18% year-over-year to $44.2 million; the trailing twelve-month figure through Dec 2025 stood at $44.2 million (up 39.18% YoY), and the FY2025 full-year result was $44.2 million, up 39.18% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $44.2 million, up from $38.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $44.2 million in Q4 2025, with the low at $1.2 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $16.0 million across 5 years, with a median of $9.9 million in 2023.
- Annual changes were most pronounced in 2021 — Total Current Liabilities jumped 35.33% — and 2022, when it soared 203.35%.
- Celcuity's Total Current Liabilities stood at $2.5 million in 2021, then jumped by 174.64% to $6.9 million in 2022, then surged by 106.19% to $14.2 million in 2023, then soared by 123.58% to $31.7 million in 2024, then soared by 39.18% to $44.2 million in 2025.
- The last three Total Current Liabilities figures came in at $44.2 million (Q4 2025), $38.8 million (Q3 2025), and $39.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 72.86 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 44.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.15 Mn |
| Sep 30, 2025 | 38.79 Mn |
| Jun 30, 2025 | 39.94 Mn |
| Mar 31, 2025 | 32.92 Mn |
| Dec 31, 2024 | 31.72 Mn |
| Sep 30, 2024 | 26.31 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | 16.70 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 12.71 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | 6.88 Mn |
| Sep 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 2.51 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | 1.54 Mn |
| Mar 31, 2021 | 1.17 Mn |